Guided Therapeutics (GTHP) Non Operating Income (2022 - 2025)
Guided Therapeutics (GTHP) reported Non Operating Income of -$48000.0 for Q2 2025, up 11.11% on a YoY basis from -$43200.0 in Q2 2024, and down 269.23% sequentially from -$13000.0 in Q1 2025.
Guided Therapeutics (GTHP) Non Operating Income (2022 - 2025) Analysis & Trends
Guided Therapeutics (GTHP) has 4 years of Non Operating Income data on file, last reported at -$48000.0 in Q2 2025.
- For the quarter ending Q2 2025, Non Operating Income rose 11.11% year-over-year to -$48000.0; the trailing twelve-month figure through Jun 2025 stood at -$272000.0 (down 423.08% YoY), and the FY2024 full-year result was -$309000.0, down 865.62% from the prior year.
- Non Operating Income retreated to -$48000.0 in Q2 2025, from -$13000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $122000.0 in Q3 2022 to a low of -$859000.0 in Q4 2022.
- A 4-year average of -$103692.3 and a median of -$52000.0 in 2023 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income soared 111.53% in 2023 and sank 219.19% in 2024, its largest moves.
- Tracing GTHP's Non Operating Income over 4 years: stood at -$859000.0 in 2022, then surged by 111.53% to $99000.0 in 2023, then slumped by 219.19% to -$118000.0 in 2024, then soared by 59.32% to -$48000.0 in 2025.
- Business Quant data shows GTHP's Non Operating Income at -$48000.0 in Q2 2025, -$13000.0 in Q1 2025, and -$118000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -18.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Guided Therapeutics | 21.96 Mn | 21.89 Mn | 458,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -48,000.00 |
| Mar 31, 2025 | -13,000.00 |
| Dec 31, 2024 | -118,000.00 |
| Sep 30, 2024 | -93,000.00 |
| Jun 30, 2024 | -54,000.00 |
| Mar 31, 2024 | -43,000.00 |
| Dec 31, 2023 | 99,000.00 |
| Sep 30, 2023 | -54,000.00 |
| Jun 30, 2023 | -52,000.00 |
| Mar 31, 2023 | -26,000.00 |
| Dec 31, 2022 | -859,000.00 |
| Sep 30, 2022 | 122,000.00 |
| Jun 30, 2022 | -209,000.00 |